Guardant Health, Inc. - Common Stock (GH)

Historical Holders from Q4 2018 to Q3 2025

Symbol: GH on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 123,850,680
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 122,485,447
Holdings value: $7,652,561,404
% of all portfolios: 0.01%
Number of holders: 385
Number of buys: 197
Number of sells: -172
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Guardant Health, Inc. - Common Stock (GH)

Filer	Ownership	Holdings Value	Nb Shares	Reporting Name	Report Period
BlackRock, Inc.	7.5%	$460,074,314	9,288,801	BlackRock, Inc.	31 Mar 2025
Deep Track Capital, LP	4.41%	$269,627,501	5,443,721	Deep Track Capital, LP	31 Mar 2025
CADIAN CAPITAL MANAGEMENT, LP	4.2%	$258,624,114	5,221,565	Cadian Capital Management, LP	31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP	3.9%	$240,233,923	4,850,271	Wellington Management Group LLP	31 Dec 2024

Institutional Holders of Guardant Health, Inc. - Common Stock (GH)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	122,485,447	$7,652,561,404	-$62,757,919	$163,653,864	$134,269,520	$62.48	385
2025 Q2	124,295,969	$6,467,826,507	+$330,760,770	$118,484,672	$76,675,736	$52.04	359
2025 Q1	118,497,703	$5,048,168,027	+$16,046,986	$97,690,320	$59,605,920	$42.6	336
2024 Q4	119,495,658	$3,649,677,643	-$152,886,448	$54,375,678	$23,168,729	$30.55	294
2024 Q3	124,539,664	$2,855,453,478	+$192,800,636	$52,895,246	$17,418,872	$22.94	264
2024 Q2	114,848,348	$3,316,872,682	+$179,592,491	$45,907,648	$18,647,776	$28.88	274
2024 Q1	111,383,571	$2,296,334,142	-$29,707,645	$33,501,056	$51,129,392	$20.63	252
2023 Q4	110,309,454	$2,983,894,470	+$45,961,733	$13,795,500	$15,056,030	$27.05	289
2023 Q3	108,297,993	$3,210,080,906	-$83,646,730	$6,479,304	$14,090,856	$29.64	289
2023 Q2	110,144,879	$3,943,258,288	+$694,610,966	$10,456,939	$13,160,080	$35.8	293
2023 Q1	92,579,337	$2,168,850,990	-$17,004,713	$7,554,312	$18,141,888	$23.44	271
2022 Q4	94,289,245	$2,564,763,814	-$199,503,944	$12,662,680	$42,682,600	$27.2	280
2022 Q3	94,962,606	$5,108,852,818	+$162,272,236	$89,187,337	$126,811,817	$53.83	310
2022 Q2	92,768,225	$3,745,003,930	-$39,996,274	$21,293,990	$70,925,862	$40.34	310
2022 Q1	92,443,619	$6,110,748,734	-$81,915,249	$22,638,000	$79,694,000	$66.24	335
2021 Q4	92,085,897	$9,209,883,362	-$251,467,115	$38,071,590	$68,931,234	$100.02	379
2021 Q3	94,130,065	$11,765,302,482	+$583,304,963	$49,284,515	$80,540,192	$125.01	365
2021 Q2	89,577,134	$11,124,047,648	-$275,498,694	$75,510,487	$80,847,235	$124.19	410
2021 Q1	91,351,911	$13,941,648,366	+$681,296,473	$84,374,870	$102,007,280	$152.65	410
2020 Q4	87,374,557	$11,260,127,731	+$219,249,861	$42,328,000	$47,020,000	$128.88	399
2020 Q3	85,443,260	$9,550,543,816	+$176,117,596	$55,140,000	$51,139,000	$111.78	341
2020 Q2	84,323,375	$6,840,933,865	+$491,051,528	$45,051,000	$18,262,000	$81.13	311
2020 Q1	78,329,707	$5,451,350,483	+$31,071,063	$35,133,000	$34,362,000	$69.6	281
2019 Q4	77,055,101	$6,021,065,515	+$259,064,552	$64,817,000	$39,702,000	$78.14	261
2019 Q3	73,811,798	$4,711,407,821	-$154,907,012	$55,819,000	$22,243,000	$63.83	230
2019 Q2	75,988,996	$6,559,989,770	+$1,412,721,312	$47,567,000	$36,292,000	$86.33	214
2019 Q1	60,292,447	$4,622,332,723	+$11,801,888	$31,486,000	$18,202,000	$76.7	144
2018 Q4	61,703,860	$2,318,551,779	+$2,050,102,770			$37.59	87